share_log

HC Wainwright & Co. Initiates Coverage On NextCure With Buy Rating, Announces Price Target of $7

HC Wainwright & Co. Initiates Coverage On NextCure With Buy Rating, Announces Price Target of $7

HC Wainwright & Co.以买入评级启动NextCure的保险,宣布目标股价为7美元
Benzinga ·  2023/08/08 06:11

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on NextCure (NASDAQ:NXTC) with a Buy rating and announces Price Target of $7.

HC Wainwright & Co. 分析师艾米丽·博德纳尔开始对NextCure(纳斯达克股票代码:NXTC)进行报道,评级为买入,并宣布目标股价为7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发